PTX-100 with photodynamic therapy casuses tumour cells to self destruct. ecancer
ecancer,
A pre-clinical study published in Nature this week indicates that a geranylgeranyl transferase inhibitor GGTI-2418, known as PTX…
Experimental drug shows promise
MedicalXpress,
Cancer cell during cell division. Credit: National Institutes of Health A collaboration between Saïd M.
PTEN counteracts FBXL2 to promote IP3R3- and Ca2+-mediated apoptosis limiting tumour growth
Bioportfolio,
In response to environmental cues that promote IP3 (inositol 1,4,5-trisphosphate) generation, IP3 receptors (IP3Rs) located on…
Experimental Drug Co-Developed by Moffitt Cancer Center Researcher Shows Promise
Newswise,
Return to Article List New study suggests GGTI-2418 can block one specific protein from binding to and degrading another…
Experimental drug co-developed by Moffitt Cancer Center researcher shows promise
Health Medicinet,
/ no comments TAMPA, Fla. (June 14, 2017) – A collaboration between Saïd M. Sebti, Ph.D., chair of Moffitt Cancer Center’s Drug…